Patent · US Active

Crystalline form of pemirolast

US9006431B2 · kind B2 · utility

0Cited by

1References

13Claims

0Family size

Assignee

RSPR Pharma AB · SE

Inventors

Anett Perlberg · Gunzgen, CH
Martin Viertelhaus · Ludwigshafen, DE
Ulrika Rosenström · Stockholm, SE
Karol Horvath · Gately Drive, SE

Key dates

Filing date	May 12, 2014
Grant date	Apr 14, 2015
Priority date	—
Expiry date	May 12, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

There is provided a hemihydrate form of the sodium salt of pemirolast.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.